์นผ์Š˜ & ๋ถ€๊ฐ‘์ƒ์„ ์ด์ƒ์ฆ

Background knowledgement

๊ด€๋ฆฌ๊ฐ€ ์ž˜ ์•ˆ ๋˜์–ด ์นผ์Š˜ ์ˆ˜์น˜๊ฐ€ ๋‚ฎ์•„์ง€๋ฉด..

1๏ธโƒฃ Hypocalcemia (์ €์นผ์Š˜ํ˜ˆ์ฆ)

Hypocalcemia
Introduction- ์ปจ๋””์…˜ ์•ˆ ์ข‹์€ ํ™˜์ž๋“ค์—๊ฒŒ์„œ๋Š” ํ”ํžˆ ๋ฐœ์ƒํ•จ.
- PTH๊ฐ€ ์ฃผ๋กœ ๊ด€์—ฌํ•˜์ง€๋งŒ, ๋ผˆ/์‹ ์žฅ/์œ„์žฅ๊ด€ ์ชฝ ์ด์ƒ์— ์˜ํ•ด์„œ๋„ ๋ฐœ์ƒ.
> 1) ์š”๊ตฌ๋Ÿ‰์ด ๋งŽ์•„์ง€๋Š” ๊ฒฝ์šฐ (๋„ˆ๋ฌด ๋งŽ์ด ์จ์„œ ์ค„์–ด๋“ฆ)
: ์ž„์‹ ํ–ˆ์„ ๋•Œ(์‚ฐ์š•๊ธฐ) : ์นผ์Š˜์ด ๋„ˆ๋ฌด ๋น ์ ธ ๋‚˜๊ฐ€์„œ ๊ฐ•์ง ์ฆ์ƒ
> 2) Increased precipitation-chelation : ์นผ์Š˜์ด ๋‹ค๋ฅธ ๋ฌผ์งˆ๊ณผ ๊ฒฐํ•ฉ๋˜์–ด ์นจ์ „
Acute onset of hyperphosphatemia : ์ธ์‚ฐ๊ณผ ๋งŽ์ด ๊ฒฐํ•ฉ
Causes- Hypoalbuminemia (์ €์•Œ๋ถ€๋ฏผํ˜ˆ์ฆ) : protein-bound calcium ๊ฐ์†Œ
- Acute/chronic kidney disease
- Critical illness - Sepsis, SIRS(systemic inflammatory response syndrome)
- Acute pancreatitis (๊ธ‰์„ฑ ์ทŒ์žฅ์—ผ) : ์ทŒ์žฅ ํšจ์†Œ ์ฆ๊ฐ€ โ†’ ์ง€๋ฐฉ์‚ฐ ์ฆ๊ฐ€ โ†’ ์นผ์Š˜๊ณผ chelation ์ฆ๊ฐ€
- Puerperal tetany (์‚ฐ์š•๊ธฐ ๊ฐ•์ง)

> ๊ทธ ์™ธ์—..
- Primary hypoparathyroidism, Ethylene glycol intoxication, Hyperphosphatemia, Iatrogenic, Intestinal malabsorption, Severe starvation
Clinical features- TCa < 6 mg/dL or iCa(ionized) < 0.8 mmol/L ๋ถ€ํ„ฐ ํ™•์—ฐํ•œ ์ž„์ƒ ์ฆ์ƒ ๋‚˜ํƒ€๋‚จ.
- ๊ธฐ๋ ฅ ์ €ํ•˜, ์‹์š• ๋ถ€์ง„, ์‹ฌํ•˜๊ฒŒ ์–ผ๊ตด์„ ๋ฌธ์ง€๋ฆ„, panting
- ๊ตญ์†Œ์  ๊ทผ์œก ๊ฒฝ๋ จ/๋–จ๋ฆผ, ๊ทผ์œก ๊ฒฝ๋ จ, ๋ปฃ๋ปฃํ•œ ๊ฑธ์Œ๊ฑธ์ด
- ๋ฐœ์ž‘, ์ดˆ์กฐ, ํ˜ผ๋ž€, ๋น„ํ‹€๊ฑฐ๋ฆผ, ๋น›๊ณผ ์†Œ๋ฆฌ์— ๊ณผ๋ฏผ ๋ฐ˜์‘
- ๋ฐœ์—ด, ํ—ˆ์•ฝ, ๊ตฌํ† , ์•ฝํ•œ ๋งฅ๋ฐ• (๋นˆ๋งฅ=์‹ฌ์žฅ์ด ์ถฉ๋ถ„ํžˆ pumping ๋ชปํ•ด์„œ ๋นจ๋ฆฌ ๋œ€=๋ง์ดˆ ๋งฅ๋ฐ•์€ ์•ฝํ•จ)
- ๊ธ‰์‚ฌ : TCa < 4 ์ผ ๋•Œ ๊ฐ€๋Šฅ์„ฑ
Diagnosis- Signalment, History taking, Physical examination
- Electrocardiography (์‹ฌ์ „๋„)
- CBC, Serum biochemical profiles
- Urinalysis
- Imaging : Radiographs, Ultrasonography
- Pancreatitis tests : TCa (Total Calcium) | iCa (ionized Calcium) | PTH (Parathyroid hormone)
- Ionized Magnesium : ์ €๋งˆ๊ทธ๋„ค์Š˜ํ˜ˆ์ฆ โ‡’ PTH ๋ถ„๋น„ ๊ฐ์†Œ
Treatment- ์ทŒ์žฅ์—ผ์ด๋‚˜, TCa๋งŒ ๋†’์•„์ง„ ๊ฒฝ์šฐ ์‹œ๊ฐ„์ด ์ง€๋‚˜๋ฉด ํšŒ๋ณต
- ์ €์นผ์Š˜ํ˜ˆ์ฆ ์ฆ์ƒ์ด๋‚˜, ์‹ฌ๊ฐํ•œ ์ˆ˜์ค€์ผ ๋•Œ(TCa < 7.5), ๋น ๋ฅด๊ฒŒ ์ง„ํ–‰๋  ๋•Œ๋Š” ์น˜๋ฃŒ ํ•„์ˆ˜
- ์นผ์Š˜ ์ฃผ์‚ฌ (1-1.5 ml/kg 10% calcium gluconate IV slowly (1 ml/min)) : ์ฒœ์ฒœํžˆ ์ฃผ์ž…ํ•˜๋ฉฐ ๊ฒฝ๊ณผ ์ง€์ผœ๋ณด๊ธฐ
- Monitoring : ์‹ ์ฒด ์ฆ์ƒ, ์นผ์Š˜ ๊ฐœ์„  ์—ฌ๋ถ€
Maintenance- ๋ช‡ ๋‹ฌ๊ฐ„ ์ง€์†, ๊ฒฝ๊ตฌ์ œ์ œ ์ด์šฉ
- Calcium ๊ณต๊ธ‰ : calcium carbonate
- ์นผ์Š˜ ์ฒ˜๋ฐฉํ–ˆ๋Š”๋ฐ ์›ํ•˜๋Š” ๋งŒํผ ํšจ๊ณผ๊ฐ€ ์•ˆ ๋‚˜ํƒ€๋‚  ๋•Œ Vitamin D ๋ณ‘์šฉ
- Vitamin D ๊ณต๊ธ‰ : Calcitriol (1,25-dihydroxyvitamin D) ์šฐ์„  ์ฒ˜๋ฐฉ
Laboratory tests
TCa (Total Calcium)= [ionized Ca] + [protein-bound Ca] + [Ca complexes]
- ์นผ์Š˜ ์ด์ƒ ์‹œ โ†’ ๋ถ€๊ฐ‘์ƒ์„ ๊ณผ ๊ฐ๋ณ„. (๋ถ€๊ฐ‘์ƒ์„ ์˜ ๊ธฐ๋Šฅ / ๋ถ„๋น„์˜ ์ด์ƒ ์œ ๋ฌด)
- ์ •์ƒ์ด๋ผ๋ฉด ๋ถ€๊ฐ‘์ƒ์„ ์˜ PTH๋ฅผ ๋†’๊ฒŒ ๋ถ„๋น„.
์ €์นผ์Š˜ ํ™˜์ž์—์„œ PTH ๋†’์œผ๋ฉด ๋ถ€๊ฐ‘์ƒ์„ ์€ ์ œ๋Œ€๋กœ ๊ธฐ๋Šฅ, but ๋‹ค๋ฅธ ์žฅ๊ธฐ ์ด์ƒ.
iCa (Ionized calcium, Ca2+)๋‹จ๋ฐฑ์งˆ์˜ ์˜ํ–ฅ์„ ๋ฐ›์ง€ ์•Š๊ณ  ์นผ์Š˜ ๋Œ€์‚ฌ์™€ ๊ฐ€์žฅ ์—ฐ๊ด€๋˜์–ด ๊ฒ€์‚ฌ
- Refernece range (dogs) : 1.2-1.5 mmol/L
- Reference range (cats) : 1.1-1.4 mmol/L
Parathyroid hormone
- intact PTH- Refernece range (dogs) : 0.5-5.8 pmol/L
- Reference range (cats) : 0-4 pmol/L
- N-terminal PTH- Refernece range (dogs) : 5-55 pg/mol/L
- Reference range (cats) : 0-4 pmol/L
Ionized magnesium์‹ ๋ถ€์ „ ์ด์ƒ์—์„œ ๋งˆ๊ทธ๋„ค์Š˜ ๋ถ€์กฑ ๋งŽ์Œ. ๋ถ€์กฑํ•˜๋ฉด โ†’ PTH ๋ถ„๋น„ ์ž˜ ๋ชปํ•จ.

2๏ธโƒฃ Renal secondary hyperparathyroidisam

์‹ ์žฅ์งˆํ™˜์— ์˜ํ•ด ๋ฐœ์ƒํ•œ ๋ถ€๊ฐ‘์ƒ์„ ํ•ญ์ง„์ฆ

  • ๊ณ ์ธ์‚ฐํ˜ˆ์ฆ(Hyperphosphatemia) : ์กฐ์ ˆ ์†๋„๋ณด๋‹ค ์Œ“์ด๋Š” ์†๋„๊ฐ€ ๋นจ๋ผ์ง€๋ฉด ๊ฐœ์„ ๋˜๊ธฐ ์–ด๋ ค์›€
  • ์ผ์„ ๋งŽ์ด ํ•˜๋Š” ์žฅ๊ธฐ๋“ค์ด ํฌ๊ธฐ๊ฐ€ ์ปค์ง: ๋ถ€๊ฐ‘์ƒ์„  ์ปค์ง€๋ฉฐ PTH ๋ถ„๋น„ ์ƒ์Šน
  • +) Calcitriol ํ•ฉ์„ฑ โ†“
๊ณ ์ธ์‚ฐํ˜ˆ์ฆ(Hyperphosphatemia)
โ†’ FGF-23 secretion โ†‘
โ†’ Calcitriol synthesis โ†“ (์นผ์Š˜ ๊ฐ์†Œ, ์ธ ๊ฐ์†Œ)
โ†’ Ionized hypocalcemia
โ†’ PTH โ†‘
โ†’ ๋ถ€๊ฐ‘์ƒ์ƒ˜์˜ diffuse hyperplasia
(= renal secondary hyperparathyroidism)

1) ์ง„๋‹จ

  • TCa, iCa, Phosphorus
  • Parathyroid hormone (PTH) : ์ฒ˜์Œ์—๋Š” ๋ถ€๊ฐ‘์ƒ์„  ํ˜ธ๋ฅด๋ชฌ๋งŒ ๋‚ฎ๊ฒŒ ์ธก์ •
  • Azotemia : BUN, creatinine, SDMA ์ฆ๊ฐ€

  • 1์ฐจ ๋ถ€๊ฐ‘๊ธฐํ•ญ : PTH ๋†’์Œ โ†’ ๋”ฐ๋ผ์„œ ์นผ์Š˜๋„ ๋†’์Œ
  • 2์ฐจ ๋ถ€๊ฐ‘๊ธฐํ•ญ : Phoshate ๋†’์Œ(๊ณ ์ธ์‚ฐํ˜ˆ์ฆ) โ†’ Calcium ๊ฐ์†Œ โ†’ PTH ๋†’์•„์ง โ†’ Calcium ์ •์ƒ์œผ๋กœ ํšŒ๋ณต
  • 3์ฐจ ๋ถ€๊ฐ‘๊ธฐํ•ญ : ๋งˆ์น˜ ์ข…์–‘์ฒ˜๋Ÿผ ๊ทธ๋ƒฅ PTH๋ฅผ ๊ณผ๋‹ค ๋ถ„๋น„. ๋‹ค ๋†’์€ ์ƒํƒœ, ์นผ์Š˜/์ธ ๋Œ€์‚ฌ๊ฐ€ ๊ฑฐ์˜ ๋ง๊ฐ€์ง„ ์ˆ˜์ค€. ์˜ˆํ›„๊ฐ€ ์•ˆ ์ข‹์€ ๋ง๊ธฐ ์ƒํƒœ๋กœ, ๋“œ๋ฌธ ์ผ€์ด์Šค.
Imaging
Renal osteodystrophy
(์‹ ์„ฑ ๊ณจ์ดํ˜•์„ฑ)
- ๋ผˆ์—์„œ ์นผ์Š˜์ด ๊ณผ๋„ํ•˜๊ฒŒ ๋น ์ ธ๋‚˜์™€ ๊ณจ๋ฐ€๋„ ๊ฐ์†Œ
- ์„ฑ์žฅ๊ธฐ(6-12๊ฐœ์›”) โ†’ ์˜คํžˆ๋ ค ๋ผˆ ๋‘๊บผ์›Œ์งˆ ์ˆ˜ ์žˆ์Œ
- ๋…ธ๋ น, CKD โ†’ Rubber jaw : ์ฝ”๊ฐ€ ๊ณ ๋ฌด์ฒ˜๋Ÿผ ๋ฌผ๋ ํ•ด์ง
- ์ƒ์•…, ํ•˜์•…, ์น˜์ฃผ๊ณจ์—์„œ ์นผ์Š˜ ๊ฐ์†Œ, ๋ผˆ ๋ฐ€๋„ ๊ฐ์†Œ
|- ์‹ ์žฅ ๊ธฐ๋Šฅ ์ €ํ•˜
|- ๋ถ€๊ฐ‘์ƒ์ƒ˜ ๋น„๋Œ€

2) ๊ด€๋ฆฌ

  • CKD๋Š” ์™„์น˜๊ฐ€ ์–ด๋ ค์šฐ๋ฏ€๋กœ ๊ด€๋ฆฌ ์œ„์ฃผ.
    • Rubber jaw ์ƒํƒœ โ†’ 2-3๋‹ฌ ์•ˆ์— ์‚ฌ๋ง (์”น์ง€ ๋ชปํ•ด์„œ)
  • Phosphorus restriction therapy
    • ์ธ ํก์ฐฉ์ œ ๋ณ‘์šฉ (mineralization ์œ„ํ—˜ ์ฃผ์˜)
    • Low-phosphate ์‹์ด
  • Calcitriol : ๊ณ ์ธ์‚ฐํ˜ˆ์ฆ์ด ์žˆ๋Š” ๊ฒฝ์šฐ, ๊ณต๋ณต์— ์ฃผ์ž…ํ•˜์—ฌ ์ธ ํก์ˆ˜๋ฅผ ์ตœ์†Œํ™”
    • Initial dose : CKD IRIS stage 2์—์„œ๋Š” 2.5-3.5ng/kg PO SID
      CKD IRIS stage 3&4์—์„œ๋Š” 2-2.5ng/kg PO SID

CKD๋ณด๋‹ค ๋ถ€๊ฐ‘๊ธฐํ•ญ ๋•Œ๋ฌธ์— ์ฃฝ๋Š” ๊ฒฝ์šฐ๋„ ๋งŽ์Œ (ํŠนํžˆ rubber jaw). ํ™˜์ž์— ๋”ฐ๋ผ ์šฐ์„ ์ˆœ์œ„๋ฅผ ๋‘๊ณ  ๊ด€๋ฆฌ.

Case 1 (Shih Tzu, 12Y4M, IF, 2.1 kg)

  • CC : intermittent vomitting 2๋…„์งธ, 2์ฃผ ์ „์— rubber jaw ๋ฐœ์ƒ.
  • ์‹ ์ฒด ๊ฒ€์‚ฌ : BCS 2/9, ํƒˆ์ˆ˜, rubber jaw, ์‹ฌ์žก์Œ
  • ํ˜ˆ์•ก ๊ฒ€์‚ฌ ๊ฒฐ๊ณผ
    • CBC) anemia
    • S/C, electrolytes) azotemia
  • urinalysis (์š”๊ฒ€์‚ฌ)
    • ๋‹จ๋ฐฑ๋‡จ๊ฐ€ ์‹ฌํ•  ๋ฒ•ํ•œํ…Œ ๊ทธ๋ ‡์ง€ ์•Š์Œ =์‚ฌ๊ตฌ์ฒด ์†์ƒ์ด ์ƒ๊ฐ๋ณด๋‹ค ์‹ฌํ•˜์ง€ ์•Š๊ฑฐ๋‚˜, ์‹ ์žฅ ๊ธฐ๋Šฅ์ด ๋„ˆ๋ฌด ๋ง๊ธฐ๋ผ ๋‹จ๋ฐฑ์งˆ์ด ์ž˜ ๋น ์ ธ๋‚˜์˜ค์ง€ ์•Š๊ฑฐ๋‚˜
  • ๋ฐฉ์‚ฌ์„  ๊ฒ€์‚ฌ
    ํ•˜์•… ๋ผˆ ์†Œ์‹ค, ์ด๋นจ ์†Œ์‹ค, ์ฒ™์ถ” ๋ผˆ ๋ฐ€๋„ ๊ฐ์†Œ,
  • ์ดˆ์ŒํŒŒ ๊ฒ€์‚ฌ
    ํ”ผ์งˆ, ์ˆ˜์งˆ ๊ฒฝ๊ณ„๊ฐ€ ์—†์Œ, hyperechoic
  • ๋ถ€๊ฐ‘๊ธฐํ•ญ ์˜์‹ฌ๋˜์–ด PTH panel ๊ฒ€์‚ฌ ์˜๋ขฐ
    • CKD IRIS stage 4 ์ง„๋‹จ
    • ์ „ํ˜•์ ์ธ renal secondary hyperparathyroidism
  • 3๊ฐœ์›” ์ •๋„ ๊ด€๋ฆฌ ๋ฐ›๋‹ค๊ฐ€, ์‹ ๋ถ€์ „ ์•…ํ™”๋กœ ์•ˆ๋ฝ์‚ฌ.
  • rubber jaw๋กœ ์™”์„ ๋•Œ๋Š” ๋ณดํ†ต ์˜ˆํ›„๊ฐ€ ์•ˆ ์ข‹๋‹ค๋Š” ๊ฑฐ,,
  • ์กฐ๊ธฐ ์ง„๋‹จํ•˜์—ฌ ๋” ์ง„ํ–‰๋˜์ง€ ์•Š๋„๋ก ๊ด€๋ฆฌํ•˜๋Š” ๊ฒŒ ์ค‘์š”.

3๏ธโƒฃ Hypercalcemia (๊ณ ์นผ์Š˜ํ˜ˆ์ฆ)

Hypercalcemia
Introduction- ๊ฐœ์™€ ๊ณ ์–‘์ด์—์„œ ๋น„๊ต์  ํ”ํ•จ
- ๋ถ€๊ฐ‘์ƒ์„  ์˜์กด์„ฑ์ธ์ง€, ๋น„์˜์กด์„ฑ์ธ์ง€ ํŒ๋‹จ
(๋ถ€๊ฐ‘์ƒ์ƒ˜์˜ PTH ์ƒ์„ฑ ์ด์ƒ โ†’ PTH ๋†’๊ณ , ์นผ์Š˜ ๋‚ฎ์Œ / ๋‹ค๋ฅธ ์›์ธ โ†’ PTH ๋‚ฎ์Œ, ์นผ์Š˜ ๋†’์Œ)
Causes- Primary hyperparathyroidism
- Renal failure
- Idiopathic hypercalcemia : ๊ณ ์–‘์ด์—์„œ๋Š” ํŠน๋ฐœ์„ฑ์œผ๋กœ๋„ ๋งŽ์ด ๋ฐœ์ƒ
- ๊ณ ์ง€ํ˜ˆ์ฆ
- ์–ด๋ฆฐ ๊ฐœ์ฒด์—์„œ๋Š” ๋†’๊ฒŒ ๋‚˜ํƒ€๋‚˜๋Š” ๊ฒฝํ–ฅ์ด ์žˆ์Œ
- Primary hyperparathyroidism
- Renal failure
- Idiopathic hypercalcemia : ๊ณ ์–‘์ด์—์„œ๋Š” ํŠน๋ฐœ์„ฑ์œผ๋กœ๋„ ๋งŽ์ด ๋ฐœ์ƒ
- ๊ณ ์ง€ํ˜ˆ์ฆ
- ์–ด๋ฆฐ ๊ฐœ์ฒด์—์„œ๋Š” ๋†’๊ฒŒ ๋‚˜ํƒ€๋‚˜๋Š” ๊ฒฝํ–ฅ์ด ์žˆ์Œ
Clinical features(=์ €์นผ์Š˜ํ˜ˆ์ฆ ์น˜๋ฃŒ ๋ถ€์ž‘์šฉ)
- ์ผ์ • ์ˆ˜์น˜ ์ด์ƒ์ด์–ด์•ผ ๋ช…ํ™•ํ•˜๊ฒŒ ๋‚˜ํƒ€๋‚จ.
- ๊ตฌํ† , ๋ฐœ์ž‘
- ๊ธ‰์‚ฌ์˜ ๊ฐ€๋Šฅ์„ฑ๋„ ์กด์žฌ (> 18~19)
- ์š”๊ฒฐ์„ ๊ด€์ฐฐ๋˜๊ธฐ๋„ ํ•จ
Diagnosis- TCa, iCa, PTH, PTHrP, Vitamin D
5๊ฐ€์ง€
Treatment
Maintenance

1) Causes

  • Primary hyperparathyroidism
  • Renal failure
  • Idiopathic hypercalcemia : ๊ณ ์–‘์ด์—์„œ๋Š” ํŠน๋ฐœ์„ฑ์œผ๋กœ๋„ ๋งŽ์ด ๋ฐœ์ƒ
  • ๊ณ ์ง€ํ˜ˆ์ฆ
  • ์–ด๋ฆฐ ๊ฐœ์ฒด์—์„œ๋Š” ๋†’๊ฒŒ ๋‚˜ํƒ€๋‚˜๋Š” ๊ฒฝํ–ฅ์ด ์žˆ์Œ

2) ์ž„์ƒ ์ฆ์ƒ (= ์ €์นผ์Š˜ํ˜ˆ์ฆ ์น˜๋ฃŒ ๋ถ€์ž‘์šฉ)

  • ์ผ์ • ์ˆ˜์น˜ ์ด์ƒ์ด์–ด์•ผ ๋ช…ํ™•ํ•˜๊ฒŒ ๋‚˜ํƒ€๋‚จ.
  • ๊ตฌํ† , ๋ฐœ์ž‘
  • ๊ธ‰์‚ฌ์˜ ๊ฐ€๋Šฅ์„ฑ๋„ ์กด์žฌ
  • ์š”๊ฒฐ์„ ๊ด€์ฐฐ๋˜๊ธฐ๋„ ํ•จ

3) ์ง„๋‹จ

  • ๋” ๋งŽ์€ ์งˆํ™˜๋“ค๊ณผ ๊ฐ๋ณ„ ํ•„์š”, Top 5 ์šฐ์„  ๊ฐ๋ณ„
  • TCa, iCa, PTH

Laboratory tests

  • Calcium-phophorus product = [total Ca] X [Phosphorase]

  • If > 60-80mg/dL โ†’ mineralization ๋ฐœ์ƒ ๊ฐ€๋Šฅ์„ฑ์ด ๋” ๋†’์Œ.

  • ์นผ์Š˜ ๋†’๊ณ  ์ธ ์ˆ˜์น˜ ๋‚ฎ์œผ๋ฉด ์˜์‹ฌํ•ด๋ณผ ์ˆ˜ ์žˆ์Œ.

  • ์นผ์Š˜, ์ธ ๋ณ€๋™ํญ์— ๋”ฐ๋ผ ์งˆํ™˜ ์œ ์ถ” ๊ฐ€๋Šฅ.

  • PTHrP

    • ๋ถ€๊ฐ‘์ƒ์„ ์€ ์ ์  ํ•  ์ผ ์—†์–ด์„œ ์œ„์ถ•.. PTH ๊ฐ์†Œ

Hypercalcemia of malignancy

Dogs
Lymphoma
Apocrine gland
  • hypercalcemia๊ฐ€ ๋ฐœ์ƒํ•˜๋Š” lymphoma๋Š” ์ข€ ๋” ์˜ˆํ›„๊ฐ€ ์•ˆ ์ข‹์Œ.

Paraneoplastic syndrome (PNS) : ์‹œํ—˜X

  • indicator
  • ~ ์„ ์šฐ์„ ์ ์œผ๋กœ ์†Œ๋น„,
  • ์ข…์–‘์ด ํฌ๋„๋‹น์„ ์†Œ๋ชจํ•ด์„œ ๋‚˜ํƒ€๋‚  ์ˆ˜๋„
  • ๋ถ€์‹  ํ”ผ์งˆ ํ˜ธ๋ฅด๋ชฌ์ด ๊ณผํ•˜๊ฒŒ ๋ถ„๋น„๋˜๊ฑฐ๋‚˜
  • sertoli cell tumor์—์„œ estrogen ๋ถ„๋น„๊ฐ€ ๊ณผ๋„ํ•˜๊ฒŒ ๋‚˜ํƒ€๋‚˜๊ฑฐ๋‚˜
Vitamin D
  • ์นผ์Š˜์ด ํ•„์š”ํ•  ๋•Œ๋Š” ์‹ ์žฅ์—์„œ ์ „ํ™˜
  • vitamin D ์ค‘๋… ์‹œ ๋‘˜ ๋‹ค ์ฆ๊ฐ€ํ•  ์ˆ˜๋„ ์žˆ๊ณ ..

  • TCa ๋จผ์ € ์ธก์ •
    • ๋†’์œผ๋ฉด โ†’ PTH ์ธก์ • (๋ถ€๊ฐ‘์ƒ์„ ์ด ๊ธฐ๋Šฅํ•˜๊ณ  ์žˆ์œผ๋ฉด PTH ๋‚ฎ๊ฒŒ ๋‚˜์™€์•ผํ•จ)
      • normal iCa โ†’ ๋‹ค์‹œ ๊ฒ€์‚ฌํ•ด๋ณด์ž
      • iCa ๋†’์œผ๋ฉด โ†’ cnrk rjatk
    • PTH ๋†’์œผ๋ฉด ๋ถ€๊ฐ‘์ƒ์„  ๊ธฐ๋Šฅ ์ด์ƒ ์˜์‹ฌ

์น˜๋ฃŒ

First-line

  • ์ˆ˜์•ก ์ฒ˜์น˜(fluid therapy) : ์นผ์Š˜ ์ด๋‡จ๊ฐ€ ๋ฐœ์ƒ
  • Physiologic saline diuresis
  • Corticosteroids
    • ๋ฆผํ”„์ข… ์ง„๋‹จ ์—†์ด ์Šคํ…Œ๋กœ์ด๋“œ ์“ฐ๋ฉด ์•ˆ๋จ,,
    • ์›์ธ์ด ํ™•์‹คํžˆ ๊ฐ๋ณ„๋˜์ง€ ์•Š์€ ์ด์ƒ ์Šคํ…Œ๋กœ์ด๋“œ ๋‚จ๋ฐœ X

Second-line

  • ์Šคํ…Œ๋กœ์ด๋“œ ์กฐ์‹ฌ์Šค๋Ÿฌ์šธ ๋•Œ, Calcitonin ๋จผ์ € ์ฃผ์‚ฌ (์นผ์Š˜ ๋–จ์–ด๋œจ๋ฆฌ๋Š” ์—ญํ• )
    • ๋“œ๋ผ๋งˆํ‹ฑํ•œ ํšจ๊ณผX, ๋ช‡ ๋ฒˆ ์“ฐ๋ฉด ๋‚ด์„ฑ์ด ์ƒ๊น€ โ†’ ์ตœ๊ทผ์—๋Š” X
  • ๋Œ€์‹  Pamidronate
    • ์›๋ž˜ ํ˜ˆ์•ก์˜ ์นผ์Š˜์„ ๋ผˆ๋กœ ๋„ฃ์–ด ๊ณจ๋‹ค๊ณต์ฆ ์น˜๋ฃŒ์— ์“ฐ์ด๋˜ ์•ฝ๋ฌผ
    • ํ˜ˆ์•ก ๋‚ด ์นผ์Š˜ ๋†๋„๋ฅผ ์ค„์ด๋Š” ๋ชฉ์ ์œผ๋กœ ์‚ฌ์šฉ

4๏ธโƒฃ Primary hyperparathyroidism (PHP)

  • ๋ถ€๊ฐ‘์ƒ์„ ์— ์ด์ƒ์ด ์ƒ๊ฒจ, ๋ถ€๊ฐ‘์ƒ์„ ์—์„œ PTH๊ฐ€ ํญ๋ฐœ์ ์œผ๋กœ ๋ถ„๋น„
  • ๊ฐœ๋‚˜ ๊ณ ์–‘์ด์—์„œ ๋“œ๋ฌผ๊ฒŒ ๋ฐœ์ƒ
  • PTH๊ฐ€ ๋†’์•„์ง€๋ฉด ๊ณ ์นผ์Š˜/์ €์ธ์‚ฐํ˜ˆ์ฆ์ด ๋ฐœ์ƒ
  • ๋Œ€๋ถ€๋ถ„์˜ ํ˜ธ๋ฅด๋ชฌ ์งˆํ™˜(์ฟ ์‹ฑ, ๊ฐ‘๊ธฐํ•ญ ๋“ฑ)๋„ ์ข…์–‘ ๋•Œ๋ฌธ์— ๋งŽ์ด ๋ฐœ์ƒ. ๋งˆ์ฐฌ๊ฐ€์ง€๋กœ ๋ถ€๊ฐ‘์ƒ์„  ์ข…์–‘์ด๋‚˜ ๋น„๋Œ€ ๋•Œ๋ฌธ์— ๋งŽ์ด ๋ฐœ์ƒ.
  • ์ข…์–‘ โ†’ hyperplasia๋Š” 4๊ฐœ๊ฐ€ ๋‹ค๊ฐ™์ด ์ปค์งˆ ๋•Œ๊ฐ€ ๋งŽ์Œ. (ํ•œ๋‘๊ฐœ ์œ ๋‚œํžˆ ํฌ๊ณ )
  • ์šฐ์„ ์ ์œผ๋กœ ๊ณ ๋ ค๋˜๋Š” ์งˆํ™˜์€ ์•„๋‹˜.

1) ์ž„์ƒ ์ฆ์ƒ

  • ์†Œ๋ณ€ ๊ด€๋ จ ์ฆ์ƒ, ๋‹ค์Œ ๋‹ค๋‡จ ์ฆ์ƒ์ด ๊ฐœ์—์„œ ๊ฐ€์žฅ ํ”ํ•จ
  • ๊ณ ์–‘์ด์—์„œ๋Š” ์‹์š• ๋ถ€์ง„, ๊ตฌํ† , ๋ชฉ์˜ ํ˜น

2) ์ง„๋‹จ

  • ์‹ ์ฒด ๊ฒ€์‚ฌ
  • ๊ณ ์–‘์ด์—์„œ ๋ชฉ์˜ ํ˜น์ด ์ž˜ ๋งŒ์ ธ์ง. โ†’ ๊ฐ‘๊ธฐํ•ญ์ด ์••๋„์ , ๊ฐ€๋” ๋ถ€๊ฐ‘๊ธฐํ•ญ
  • ํ•œ ๊ฐœ ๋น„๋Œ€๊ฐ€ ๋Œ€๋ถ€๋ถ„. 2๊ฐœ ๋น„๋Œ€ : 10%, 3๊ฐœ ์ด์ƒ ๊ฑฐ์˜ ์—†์Œ

3) ์น˜๋ฃŒ

  • hypercalcemia treatment

  • surgical removal : ์ˆ˜์ˆ ํ•ด๋„ ์˜ˆํ›„ ๋ถˆ๋Ÿ‰

    • ๊ฐ‘์ƒ์„ ์— ๋ถ™์€ ๋ถ€๊ฐ‘์ƒ์„  ์ ˆ์ œ
    • ๋‚˜๋จธ์ง€ ๋ถ€๊ฐ‘์ƒ์„ ์ด ์œ„์ถ•๋˜์–ด ์žˆ์„ ์ˆ˜ ์žˆ์œผ๋‹ˆ, ํšŒ๋ณต๋  ๋•Œ๊นŒ์ง€ ์นผ์Š˜ ๊ธ‰์—ฌ ๊ณ„์†
    • ์ˆ˜์ˆ  ์งํ›„ : ์นผ์Š˜ ์ž”๋œฉ ์ฃผ๋ฉด์„œ hypocalcemia ์ฆ์ƒ ๋‚˜ํƒ€๋‚˜์ง€ ์•Š๋„๋ก ์นผ์Š˜ ๊ณ„์† ๋ณต์šฉ
    • ํ•œ๋™์•ˆ ์‚ฐ์ฑ… ์ œํ•œ : ์‚ฐ์ฑ… ์งํ›„ ๊ทผ๊ฐ•์ง์ด ๋‚˜ํƒ€๋‚  ์ˆ˜ ์žˆ์Œ
  • chemical

  • ๋น„์นจ์Šต์  ์น˜๋ฃŒ

    • Percutaneous ultrasonography-guided ethanol ablation (with 96% ethanol)
    • Percutaneous ultrasonography-guided radiofrequency heat ablation
    • ์ˆ˜์ˆ ์— ๋น„ํ•ด ๋œ ์•„ํ”Œ ์ˆ˜ ์žˆ์œผ๋‚˜, ์ ˆ์ œ ํ›„ ์กฐ์ง ๊ฒ€์‚ฌ๋ฅผ ๋ณด๋‚ด์„œ adenoma, calcinoma, cycoplasma ๋“ฑ ์กฐ์ง๋ณ‘๋ฆฌํ•™์  ํ‰๊ฐ€๊ฐ€ ๊ฐ€๋Šฅํ•œ ๊ฒƒ๊ณผ ๋‹ฌ๋ฆฌ ๊ทธ๋ƒฅ ์—†์• ๋ฒ„๋ ค์„œ ํ‰๊ฐ€ x
    • ์ผ๋ฐ˜์ ์œผ๋กœ ์‹œ์ˆ ๋ณด๋‹ค ์ˆ˜์ˆ  ๊ถŒ์žฅ